Renalytix Plc
RENXF
$0.091
-$0.039-30.00%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.92% | 9.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.92% | 9.53% | |||
| Cost of Revenue | -23.27% | -8.49% | |||
| Gross Profit | 177.78% | 154.55% | |||
| SG&A Expenses | -27.61% | 16.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.50% | -8.39% | |||
| Operating Income | 25.94% | 9.96% | |||
| Income Before Tax | 33.19% | 8.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.16% | 8.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.16% | 8.64% | |||
| EBIT | 25.94% | 9.96% | |||
| EBITDA | 26.14% | 10.02% | |||
| EPS Basic | 12.70% | 35.44% | |||
| Normalized Basic EPS | 4.80% | 35.73% | |||
| EPS Diluted | 12.70% | 36.00% | |||
| Normalized Diluted EPS | 4.80% | 35.73% | |||
| Average Basic Shares Outstanding | -23.50% | 41.48% | |||
| Average Diluted Shares Outstanding | -23.50% | 41.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
